InsiderFlow

Jonathan Zalevsky

NKTR

Jonathan Zalevsky serves as Chief R&D Officer at Nektar Therapeutics (NKTR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

25 trades

$2.05M

Net Position

Net Seller

$2.05M

Companies Traded

1

NKTR

Active Period

May 2021 – Feb 2026

25 total trades

Most Recent

Sell NKTR

Feb 18, 2026 · $13.1K

Jonathan Zalevsky's Insider Trading at Nektar Therapeutics (NKTR)

Buys

0 · $0.00

Sells

25 · $2.05M

Total Shares Bought

0

Total Shares Sold

340,869

NKTR Price Chart
Loading chart...
DateTypeValue
Feb 18, 2026 Sell$13.1K
Jan 22, 2026 Sell$137.9K
Nov 25, 2025 Sell$62.8K
Sep 8, 2025 Sell$57.7K
Sep 4, 2025 Sell$14.6K
Aug 21, 2025 Sell$19.3K
May 21, 2025 Sell$7.2K
Feb 21, 2025 Sell$10.4K
Dec 20, 2024 Sell$48.0K
Nov 20, 2024 Sell$7.9K
Aug 20, 2024 Sell$8.8K
May 20, 2024 Sell$12.9K
Feb 22, 2024 Sell$6.1K
Nov 20, 2023 Sell$4.7K
Aug 17, 2023 Sell$7.6K
May 17, 2023 Sell$7.0K
Feb 17, 2023 Sell$31.5K
Nov 18, 2022 Sell$48.1K
Aug 19, 2022 Sell$342.8K
Aug 17, 2022 Sell$50.3K
May 17, 2022 Sell$85.6K
Feb 18, 2022 Sell$119.5K
Nov 17, 2021 Sell$274.6K
Aug 18, 2021 Sell$106.0K
May 19, 2021 Sell$569.3K